Prediction Case File
YouTubeTracking Live

Hyperliquid Price Prediction 📈

1 extracted signal · 0 resolved · 1 still active

EllioTrades profile imageEllioTradesIndependent analyst profile
Source published
11 Nov 2026, 17:44 UTC
Recorded by Tahlil Plus
11 Nov 2026, 19:45 UTC
Video preview for Hyperliquid Price Prediction 📈
Source overview

AI-generated source summary

The speaker analyzes the potential price trajectory of Hyperliquid (HYPE) following news of its integration with the Intercontinental Exchange (ICE), the parent company of the NYSE, for perpetual futures. With current prices in the $70s, the speaker projects a base case target of over $200, with extreme bullish scenarios reaching $400, driven by expected exponential increases in daily revenue and mainstream financial adoption.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

EllioTrades

Platform-wide history, separate from this source evaluation.

Reliability
60.0
Tracked signals
31
Historical success
59.1%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail